Clinical Chemistry: An Overview

Portada
N.C. den Boer
Springer Science & Business Media, 1 feb 1989 - 874 páginas
The XIIIth International and the VIIth European Congress of Clinical Chemistry took place at the Netherlands Congress Centre in The Hague, from June 28th to July 3rd 1987. The Organizing Committee and the Scientific Committee for these combined congresses aimed to present the state-of-the-science as well as the state-of-the-art for those fields of clinical chemistry which show a strong progress and which will most probably inflict a great part of all clinical chemists. "Clinical Chemistry, an Overview" comprises almost all papers which were presented during the congress in 5 plenary lectures and 97 lectures during 24· symposia. The invited speakers, being experts in their fields of clinical chemistry, succeeded very well in presenting an overview over the newest developments in connection to the knowledge already known, thereby demonstrating the progress made in clinical chemistry during the last years. The Editors take great pleasure in thanking once more the members of the Scientific Committee and of the International Scientific Advisory Board in creating an excellent scientific programme for this congress. The Editors also take great pleasure in thanking all those whose afforts have made possible the publication of this book. We are most grateful to all speakers who also prepared a manuscript for publication. The Editors also appreciate the most helpful and encouraging attitude of Plenum Press Publishers Corporation.
 

Índice

CHAPTER 1
1
THE INTERACTION BETWEEN INDUSTRY AND THE CLINICAL CHEMIST
3
HIGH RESOLUTION NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY IN CLINICAL CHEMISTRY AND DISEASE DIAGNOSIS
9
THE INFLUENCE OF REFUNDING OF COST ON THE ORGANIZATION OF CLINICAL LABORATORIES
27
THE ROLE OF CLINICAL CHEMISTRY IN PREVENTIVE MEDICINE
33
GENES GENETECHNOLOGY AND DNAPROBES
43
RECOMBINANT DNA TECHNOLOGY IN THE DIAGNOSIS OF HUMAN INHERITED DISEASE
45
GENETIC HETEROGENEITY AND CLINICAL DIVERSITY
55
TOOL FOR PREDICTION OF CORONARY ATHEROSCLEROSIS
455
LABORATORY MANAGEMENT AND COST EFFECTIVENESS
461
CAN THE QUALITY OF LABORATORY TESTING BE MAINTAINED AT REDUCED COST?
463
MANAGEMENT AND ORGANIZATION OF CLINICAL CHEMISTRY AND LABORATORY DIAGNOSTICS IN GDR
471
THE ORGANIZATION OF THE NATIONAL HEALTH SERVICE AND ITS CONSEQUENCE FOR THE CLINICAL CHEMISTRY LABORATORY...
481
THE ORGANISATION OF THE NATIONAL HEALTH CARE AND ITS CONSEQUENCES ON THE CLINICAL CHEMISTRY LABORATORY IN ...
487
LIPIDS
497
CLINICAL SIGNIFICANCE OF LIPOPROTEIN PARTICLES
499

MOLECULAR BIOLOGY OF THE HUMAN ALDOLASE ISOENZYME GENE FAMILY
63
THERAPEUTIC DRUG MONITORING AND TOXICOLOGY
73
RELEVANCE OF MEASURING METABOLITES
75
BIOLOGICAL MONITORING OF EXPOSURE TO TOXIC TRACE ELEMENTS
83
The impact of technological developments
93
CONSEQUENCES FOR TREATMENT
103
BIOSENSORS AND BIOCHIPS
111
BIOSENSORS FOR MEDICAL USE
113
ENZYME SENSORS AND IMMUNOSENSORS
121
AUTOIMMUNE ENDOCRINOLOGICAL AND NEUROLOGICAL DISORDERS
129
ANTIBODIES TO THE THYROTROPIN TSH RECEPTOR AND AUTOIMMUNE THYROID DISEASE
131
PREDICTING TYPE I DIABETES
143
ANTIBODIES TO ACETYLCHOLINE RECEPTORS IN MYASTHENIA GRAVIS
151
POLYGLANDULAR AUTOIMMUNE SYNDROME AND BRONCHIAL ASTHMA
159
COAGULATION
177
FIBRINOLYSIS
179
MODULATION OF ENDOTHELIAL CELL COAGULANT PROPERTIES
217
DEFICIENCIES OF PROTEIN C AND PROTEIN S AND THROMOEMBOLIC DISEASE
221
RHEUMATIC DISEASES
227
BIOCHEMICAL EVENTS IN THE DESTRUCTION OF CARTILAGE IN RHEUMATIC DISEASES
229
NEW IMMUNOLOGICAL ASPECTS IN THE PATHOGENESIS AND DIAGNOSIS OF RHEUMATIC DISEASES
235
NEW BIOCHEMICAL PARAMETERS IN THE DIAGNOSIS OF JOINT DISEASES
241
CLINICAL BIOCHEMISTRY OF GOUT
257
ION SELECTIVE ELECTRODES
267
ION SELECTIVE ELECTRODES ISES IN CLINICAL CHEMISTRY
269
PROPOSED RECOMMENDATIONS ON IONSELECTIVE ELECTRODE DETERMINATIONS OF THE SUBSTANCE CONCENTRATION OF SO...
277
THE CLINICAL APPLICATION OF IONIZED CALCIUM
295
SODIUM AND POTASSIUM BY ION SELECTIVE ELECTRODES CLINICAL INTERPRETATION
303
BEDSIDE CHEMISTRY AND SELFTESTING
309
CLINICAL BIOCHEMISTRY AN INTEGRATED SERVICE
311
EXPERIENCES FROM PRIMARY HEALTH CARE IN THE NORDIC COUNTRIES
319
BEDSIDE CHEMISTRY
327
CLINICAL CHEMICAL ASPECTS OF TRANSPLANTATION
335
RELEVANT ISSUES IN CLINICAL ORGAN TRANSPLANTATION
337
BIOCHEMICAL ASPECTS OF TRANSPLANTATION
345
HLA CLASS II ANTIGENS SIGNIFICANCE IN ORGAN TRANSPLANTATION
355
PROGNOSTIC OUTLOOK OF ORGAN TRANSPLANT RECIPIENTS THROUGH AN IMMUNOLOGICAL VIEW
365
ENZYMOLOGY
375
NEW PERSPECTIVES IN CLINICAL ENZYMOLOGY
377
STRUCTURE AND FUNCTION OF DISEASERELATED ALLELOZYMES
385
THE CLINICAL ENZYMOLOGY OF THE COMPLEMENT SYSTEM
387
CHEMI AND BIOLUMINESCENCE
397
LUMINESCENCE IMMUNOASSAYS
399
LUMINESCENCE METHODS FOR SUBSTRATE AND ENZYME DETERMINATIONS
405
PHAGOCYTE CHEMILUMINESCENCE AND IMMUNE CELL INTERACTION
415
PHAGOCYTOSISINDEPENDENT CHEMILUMINESCENCE
425
CLINICAL CHEMICAL ASPECTS OF AGEING
433
EPIDEMIOLOGY THEORIES AND MODEL SYSTEMS
435
CHANGES DURING AGEING IN IMMUNOLOGY PROTEINS ENZYMES AND HORMONES
443
CLINICAL BIOCHEMISTRY OF CONNECTIVE TISSUE AND ITS ROLE IN AGEING
447
OBSERVATIONS ON LIPID METABOLISM IN TWO EXPERIMENTS OF NATURE AND ONE EXPERIMENT OF HUMAN CULTURE
509
SYMPOSIUM FLOWCYTOMETRY
525
HISTORY AND HORIZONS
527
CURRENT AND FUTURE PROSPECTS OF FLOW CYTOMETRY IN CLINICAL HAEMATOLOGY
535
CLINICAL CHEMISTRY AND NUTRITION
543
SOME BIOCHEMICAL AND CLINICAL ASPECTS
545
GROWTH FACTORS IN MALNUTRITION
557
THE USE OF BIOCHEMICAL PARAMETERS TO EVALUATE AND TO ESTIMATE THE NUTRITIONAL STATUS OF KIDNEY PATIENTS
561
CLINICAL BIOCHEMICAL PARAMETERS TO BE USED IN GENERAL AS INDICATORS OF MALNUTRITION OF CHILDREN IN DEVELOPI...
567
MASSSPECTROMETRY
577
PRINCIPLES AND APPLICATIONS OF MASS SPECTROMETRY IN CLINICAL CHEMISTRY
579
MODERN MASS SPECTROMETRIC TECHNIQUES APPLIED TO THE ANALYSIS OF STEROIDS
589
MASS SPECTROMETRY AND THE DIAGNOSIS AND STUDY OF METABOLIC DISEASE
597
ISOTOPE DILUTION MASS SPECTROMETRY AS A REFERENCE METHOD
603
QUALITY ASSURANCE
613
EXPERT SYSTEMS FOR THE CLINICAL INTERPRETATION OF LABORATORY REPORTS
615
QUALITY CONTROL IN CLINICAL LABORATORIES
629
HUMAN INFERTILITY
641
CLINICAL ASPECTS OF FEMALE INFERTILITY
643
BASIC AND CLINICAL CONCEPTS OF A NEW TREATMENT FOR INFERTILITY OF VARIOUS CASES
649
FUTURE POSSIBILITIES IN REPRODUCTIVE MEDICINE
661
CLINICAL IMMUNOLOGY
673
FROM THE GENE TO THE BEDSIDE
675
NEW CONCEPTS IN THE ETIOPATHOGENESIS OF SYSTEMIC LUPUS ERYTHEMATOSUS
685
IGEMEDIATED HYPERSENSITIVITY
693
RECENT ADVANCES IN OUR KNOWLEDGE OF COMPLEMENT
699
REGULATORY PEPTIDES
705
A MOLECULAR MARKER FOR SCHIZOPHRENIA?
707
REGULATORY PEPTIDES IN THE CONTROL OF FOOD INTAKE
715
REGULATORY PEPTIDES IN HEALTH AND DISEASE
723
EVIDENCE FOR OVARIAN PARTICIPATION
729
THE THYROID AND FUNCTIONING HORMONES
737
CELLULAR ASPECTS OF THYROID HORMONES
739
METHODS OF ANALYSIS OF THYROIDRELATED HORMONES
743
THYROTROPIN SECRETION IN HEALTH AND DISEASE
751
VETERINARY CLINICAL CHEMISTRY
759
BIOCHEMICAL DISORDERS IN NONHUMAN PRIMATES WITH HYPERBILIRUBINEMIAS
761
BIOCHEMICAL ALTERATIONS IN LIVER DISEASES OF DOMESTIC ANIMALS
769
DIFFERENCES BETWEEN SPECIES
781
LIPID METABOLISM IN LARGE ANIMALS
789
CLINICAL BIOCHEMISTRY IN DEVELOPING COUNTRIES
797
CLINICAL BIOCHEMISTRY IN DEVELOPING COUNTRIES IN ASIA
799
CLINICAL BIOCHEMISTRY SERVICES IN TROPICAL AFRICA
815
CLINICAL BIOCHEMISTRY SERVICES IN INDIA
825
CLINICAL BIOCHEMISTRY SERVICES IN INDONESIA
833
SUMMARY AND POSSIBLE SOLUTIONS
841
AUTHOR INDEX
847
SUBJECT INDEX
849
Página de créditos

Otras ediciones - Ver todo

Términos y frases comunes

Información bibliográfica